Lion Biotechnologies (LBIO) PT Raised to $20 at Chardan Capital Markets, "Leader In Precision Immuno-Oncology"
Get Alerts LBIO Hot Sheet
Price: $6.95 --0%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Join SI Premium – FREE
Chardan Capital Markets raised its price target on Lion Biotechnologies (NASDAQ: LBIO) to $20.00 (from $17.50) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veritone (VERI) PT Lowered to $5 at Needham
- Braze Inc (BRZE) PT Raised to $35 at BTIG
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Chardan Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share